Articles about Product Safety

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

Independent Research Finds 77% Of Commercial Sunscreens Fail Efficacy Or Contain Hidden Chemical UV Filters, Sky & Sol Ranked #1 Zinc Oxide Sunscreen For 2026.

Today 22:32 EDT

Via AB Newswire

Suncare Empowers Global Healthcare Procurement: A Strategic Guide to Selecting Top-Tier Medical Rehabilitation Equipment Suppliers

Today 22:16 EDT

Via AB Newswire

Kaplan Fox Continues to Alert Investors of Capricor Therapeutics, Inc. (NASDAQ: CAPR) to a Class Action Deadline on September 28, 2026

Today 18:00 EDT

Via NewMediaWire

Kilo Pairs LoRaWAN, mioty and AI Rules for Cold Storage Alarms

Today 16:55 EDT

Via AB Newswire

Jazz Pharmaceuticals (JAZZ) Stock Trades Up, Here Is Why

Today 16:00 EDT

Via StockStory

Why Rule Breakers Buy a Stock That's Already "Won" ↗

Today 15:57 EDT

Via The Motley Fool

FDA Clears First Targeted Dermatomyositis Treatment From Roivant ↗

Today 14:37 EDT

Via Benzinga

Protagonist Wins FDA Approval for MIMRYLO in Rare Blood Cancer Treatment ↗

Today 14:02 EDT

Via MarketBeat

Cytokinetics Investors Weigh Safety Data From Pivotal Trial ↗

Today 13:43 EDT

Via Benzinga

FDA Approves Gilead's New Single Tablet HIV Regimen ↗

Today 13:38 EDT

Via Benzinga

Capricor Therapeutics, Inc. Notice of September 28, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

Today 13:10 EDT

Via Newsfile

Takeda Secures FDA Approval For First-In-Class Blood Cancer Drug ↗

Today 12:38 EDT

Via Benzinga

Capricor Therapeutics, Inc. (CAPR) Securities Fraud Class Action Lawsuit Filed; September 28, 2026, Lead Plaintiff Deadline

Today 10:15 EDT

Via NewMediaWire

BioMedNewsBreaks — NanoViricides (NYSE American: NNVC) Advances NV-387 Measles Treatment Program Toward Phase II Trial

Today 10:03 EDT

Via Investor Brand Network

NetworkNewsBreaks – Oragenics Inc. (NYSE American: OGEN) Advances Phase IIa Concussion Trial, Provides FDA and Listing Updates

Today 9:15 EDT

Via Investor Brand Network

Navigating US FDA Post-Market Compliance and Pharmacovigilance in 2026 ↗

Today 7:48 EDT

Via Talk Markets

Generative AI in Clinical Trial Market: Size, Trends, and Strategic Insights to 2033 ↗

Today 6:50 EDT

Via Talk Markets

KDL Disposable Enteral Oral Feeding Syringe

August 30, 2026

Via AB Newswire

Bulk Customization Solution for Sustainable EcoFriendly Gifts

August 29, 2026

Via AB Newswire

Markets and clients – Industry Trends and Best Practices

August 29, 2026

Via AB Newswire

Capricor Therapeutics, Inc. (CAPR) Action Lawsuit: Investors Face September 28, 2026, Deadline

August 29, 2026

Via NewMediaWire

Kaplan Fox Encourages Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors to Contact the Firm Before the Deadline on September 28, 2026

August 28, 2026

Via NewMediaWire

Capricor Therapeutics, Inc. Notice of September 28, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

August 28, 2026

Via Newsfile

Crypto News: Pepeto Announces Its DeFi Toolkit While Bitcoin Price Prediction Hits $250,000

August 28, 2026

Via First Publisher

TechMediaBreaks – SS Innovations International Inc. (NASDAQ: SSII) Advances Global Robotic Surgery Strategy with SSi Mantra Platform

August 28, 2026

Via Investor Brand Network

Revolution Medicines Wins FDA Approval for RASONQUE in Metastatic Pancreatic Cancer ↗

August 28, 2026

Via MarketBeat

Roivant Sciences Wins FDA Approval for LISRAYA in Dermatomyositis, Launches Immediately ↗

August 28, 2026

Via MarketBeat

72 Million Vehicles Have an Open Automotive Recall: Recall Wire News Launches an AI-Native Platform to Make That Information Usable for Every Driver

August 28, 2026

Via Press Release Distribution Service

Cytokinetics’ Aficamten Hits Dual Phase III Endpoints in Non-Obstructive HCM ↗

August 28, 2026

Via MarketBeat

INVESTOR ALERT: Capricor Therapeutics, Inc. (CAPR) Investors With Substantial Losses Have Opportunity to Lead Class Action Lawsuit

August 28, 2026

Via NewMediaWire

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.